Liver Pseudolymphoma (Reactive Lymphoid Hyperplasia): Difficulty in
Radiological and Pathological Diagnosis

Suleyman      Bakdik; Necdet      Poyraz; Teyfik      Kucukkartallar; Pembe      Oltulu

doi:10.2174/1573405617666210504120142

Abstract

Background: Pseudolymphoma of the liver (Reactive Lymphoid Hyperplasia) (RLH) is a rare condition. It is usually asymptomatic and detected incidentally on radiological imaging. Imaging features are similar to hepatic adenoma, hepatocellular carcinoma, cholangiocarcinoma, and malignant lymphoma and are not specific for pseudolymphoma of the liver. Percutaneous core biopsy is insufficient to distinguish pseudolymphoma of the liver from low-grade malignant lymphoma and extranodal marginal lymphomas.

Case Descriptions: In this article, we present a case of hepatic RLH of a patient who was presented with a skin rash on the leg and was detected incidentally on radiological imaging.

Conclusion: Preoperative definitive diagnosis of hepatic RLH using various imaging methods, including MRI with hepatocellular agents, is highly difficult.

Keywords: Pseudolymphoma, reactive lymphoid hyperplasia, mimicking hepatocellular carcinoma, MRI, benign lesion, germinal center.

Graphical Abstract

[1] 
Iwamuro M, Kawai Y, Takata K, et al. Reactive lymphoid hyperplasia with a lipomatous component associated with fecal compaction in an appendiceal orifice.  Inter Med  2014; 53: 1049-53.
[http://dx.doi.org/10.2169/internalmedicine.53.1635] 
[2] 
Bois MC, Sekiguchi H, Ryu JH, et al. No definite clinical features of immunoglobulin G4-related disease in patients with pulmonary nodular lymphoid hyperplasia.  Hum Pathol  2017; 59: 80-6.
[http://dx.doi.org/10.1016/j.humpath.2016.09.016] 
[3] 
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: A systematic review.  Acta Derm Venereol  2018; 98: 310-7.
[http://dx.doi.org/10.2340/00015555-2841] 
[4] 
Onoda N, Ohsawa M, Kawajiri H, et al. Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: A case report.  J Med Case Rep  2014; 8: 247.
[http://dx.doi.org/10.1186 / 1752-1947-8-247] 
[5] 
Andrew NH, Kearney D, Selva D. Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia. Eye (Lond)  2013; 27(4): 561-3.
[http://dx.doi.org/10.1038/eye.2012.288] [PMID: 23348726] 
[6] 
Taguchi K, Kuroda S, Kobayashi T, et al. Pseudolymphoma of the liver: A case report and literature review.  Sur Case Rep  2015; 1: 107.
[http://dx.doi.org/10.1186/s40792-015-0110-9] 
[7] 
Zhang W, Zheng S. Reactive lymphoid hyperplasia of the liver, A case report.  Medicine  2019; 98(30): e16491.
[http://dx.doi.org/10.1097/MD.0000000000016491] 
[8] 
Snover DC, Filipovich AH, Dehner LP, Krivit W. ‘Pseudolymphoma’. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. Arch Pathol Lab Med  1981; 105(1): 46-9.
[PMID: 6893912] 
[9] 
Caputo D, Cartillone M, Coppola R. All that glitters are not gold! Reactive lymphoid hyperplasia mimicking colorectal liver metastases: Description of a case and literature review.  Updates Surg  2017; 69: 113-5.
[http://dx.doi.org/10.1007/s13304-017-0416-1] 
[10] 
Higashi T, Hashimoto D, Hayashi H, et al. Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma.  Surg Case Rep  2015; 1: 31.
[http://dx.doi.org/10.1186/s40792-015-0034-4] 
[11] 
Sato K, Ueda Y, Yokoi M, et al. Reactive lymphoid hyperplasia of the liver in a patient with multiple carcinomas: A case report and brief review.  J Clin Pathol  2006; 59: 990-2.
[12] 
Kunimoto H, Morihara D, Nakane SI, et al. Hepatic pseudolymphoma with an occult hepatitis B virus infection.  Inter Med  2018; 57: 223-30.
[http://dx.doi.org/10.2169/internalmedicine.8981-17] 
[13] 
Ohtsu T, Sasaki Y, Tanizaki H, et al. Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B.  Inter Med  1994; 33: 18-22.
[http://dx.doi.org/10,2169/internalmedicine.33.18] 
[14] 
Tanizawa T, Eishi Y, Kamiyama R, et al. Reactive lymphoid hyperplasia of the liver characterized by an angiofollicular pattern mimicking Castleman's disease.  Pathol Int  1996; 46: 782-6.
[http://dx.doi.org/10.1111/j.1440-1827.1996.tb03549.x] 
[15] 
Song KD, Jeong WK. Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver.  Clin Mol Hepatol  2015; 21: 187-91.
[http://dx.doi.org/10.3350/cmh.2015.21.2.187] 
[16] 
Zhou Y, Wang X, Xu C, Zhou G, Zeng M, Xu P. Hepatic pseudolymphoma: Imaging features on dynamic contrast-enhanced MRI and diffusion-weighted imaging.  Abdom Radiol (NY)  2018; 43(9): 2288-94.
[http://dx.doi.org/10.1007/s00261-018-1468-5] 
[17] 
Koss MN, Hochholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: A study of 161 patients.  Hum Pathol  1983; 14: 1024-38.
[http://dx.doi.org/10.1016/S0046-8177(83)80258-5] 
[18] 
Kulow BF, Cualing H, Steele P, et al. Progression of cutaneous B- cell pseudolymphoma to cutaneous B-cell lymphoma.  J Cutan Med Surg  2002; 6: 519-28.
[http://dx.doi.org/10.1007/s10227-001-0133-7] 
[19] 
Kwon YK, Jha RC, Etesami K, et al. Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge.  World J Hepatol  2015; 7: 2696-702.
[http://dx.doi.org/10.4254/wjh.v7.i26.2696] 
[20] 
Lv A, Liu W, Qian HG, Leng JH, Hao CY. Reactive lymphoid hyperplasia of the liver mimicking hepatocellular carcinoma: incidental finding of two cases. Int J Clin Exp Pathol  2015; 8(5): 5863-9.
[PMID: 26191310] 

Rights & Permissions Print Cite

Article Metrics

27

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573405617666210504120142	Print ISSN 1573-4056
Publisher Name Bentham Science Publisher	Online ISSN 1875-6603

Current Medical Imaging

Liver Pseudolymphoma (Reactive Lymphoid Hyperplasia): Difficulty in Radiological and Pathological Diagnosis

Abstract Play Pause

Graphical Abstract

Related Books

Abstract